Free Trial

Spectral Medical (TSE:EDT) Stock Price Crosses Above 50-Day Moving Average - Here's What Happened

Spectral Medical logo with Medical background

Key Points

  • Spectral Medical Inc. shares have recently crossed above the 50-day moving average, signaling a potential bullish trend, with the last traded price at C$1.48.
  • The company's market cap is C$416.25 million and it reported a PE ratio of -21.14, indicating financial challenges.
  • Spectral Medical focuses on the development of treatments for septic shock, utilizing its endotoxin activity assay (EAA) and toraymyxin therapeutic.
  • Looking to export and analyze Spectral Medical data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Spectral Medical Inc. (TSE:EDT - Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.92 and traded as high as C$1.50. Spectral Medical shares last traded at C$1.48, with a volume of 390,549 shares changing hands.

Spectral Medical Price Performance

The stock's 50-day moving average price is C$0.94 and its 200 day moving average price is C$0.83. The firm has a market capitalization of C$425.87 million, a price-to-earnings ratio of -21.29 and a beta of -0.18. The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

Featured Stories

Should You Invest $1,000 in Spectral Medical Right Now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines